Are aromatase inhibitors associated with higher myocardial infarction risk in breast cancer patients? A Medicare population‐based study

BACKGROUND: Theoretically, the estrogen deprivation induced by aromatase inhibitors (AIs) might cause ischemic heart disease, but empiric studies have shown mixed results. We aimed to compare AIs and tamoxifen with regard to cardiovascular events among older breast cancer patients outside of clinica...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Cardiol
Asıl Yazarlar: Kamaraju, Sailaja, Shi, Yushu, Smith, Elizabeth, Nattinger, Ann B., Laud, Purushottam, Neuner, Joan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wiley Periodicals, Inc. 2018
Konular:
Clinical Investigations
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344290/
https://ncbi.nlm.nih.gov/pubmed/30443921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23114
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller